Substituted tetrahydro-1H-pyrido[4,3-b]indoles as serotonin receptors agonists and antagonists
申请人:Lee Taekyu
公开号:US20070027178A1
公开(公告)日:2007-02-01
The present application describes compounds, including all pharmaceutically acceptable salts, prodrugs, solvates and stereoisomers thereof, according to Formula I, pharmaceutical compositions, comprising at least one compound according to Formula I and optionally at least one additional therapeutic agent and methods of treating various diseases, conditions and disorders associated with modulation of serotonin receptors such as, for example: metabolic diseases, which includes but is not limited to obesity, diabetes, diabetic complications, atherosclerosis, impared glucose tolerance and dyslipidemia; central nervous system diseases which includes but is not limited to, anxiety, depression, obsessive compulsive disorder, panic disorder, psychosis, schizophrenia, sleep disorder, sexual disorder and social phobias; cephalic pain; migraine; and gastrointestinal disorders using compounds according to Formula I
本申请描述了化合物,包括所有药用盐、前药、溶剂合物和其立体异构体,根据式I,包括至少一种根据式I的化合物的药物组合物,以及可选择地至少一种额外的治疗剂,以及使用根据式I的化合物治疗与调节5-羟色胺受体相关的各种疾病、状况和紊乱的方法,例如:代谢性疾病,包括但不限于肥胖症、糖尿病、糖尿病并发症、动脉粥样硬化、葡萄糖耐量受损和血脂异常;中枢神经系统疾病,包括但不限于焦虑症、抑郁症、强迫症、惊恐症、精神病、精神分裂症、睡眠障碍、性功能障碍和社交恐惧症;头痛;偏头痛;和胃肠道疾病。